- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
HbA1c metrics may predict CAC and CVD events in type 1 diabetes patients
USA: Several HbA1c metrics positively correspond with coronary artery calcium (CAC) volume and independently predict incident cardiovascular disease (CVD) events in type 1 diabetes, findings from CACTI Study have shown.
"Even after adjustment for numerous CVD risk factors, these associations with CVD events persisted for mean HbA1c, baseline HbA1c, and time-varying HbA1c," the researchers wrote in their study published in The Journal of Clinical Endocrinology & Metabolism.
Interventions that decrease mean glucose have lowered macro- and microvascular complication rates in type 1 diabetes (T1D). However, there is a difference in CV risk between type 1 diabetes patients and the general population, indicating that factors beyond HbA1c normalization drive cardiovascular outcomes.
Against the above background, William B Horton from the University of Virginia School of Medicine in Charlottesville, VA, and colleagues aimed to determine whether various HbA1c metrics predict anatomic CVD risk factors and events in people with type 1 diabetes.
For this purpose, the researchers used linear regression to analyze the relationship between various HbA1c metrics and anatomic CVD risk factors. Cox regression was used to model their relationship to incident CVD events in the CACTI Study.
The study revealed the following findings:
- In linear regression models adjusted for age, sex, and T1D duration, baseline Hba1c (b = 0.3998), mean HbA1c (b = 0.5385), and HbA1c standard deviation (SD) (b = 1.1521) were each positively associated with square root transformed coronary artery calcium volume.
- Only mean HbA1c (b = 1.659) was positively associated with pericardial adipose tissue volume.
- In survival models adjusted for age, sex, and T1D duration, baseline HbA1c (HR: 1.471), mean HbA1c (HR: 1.850), time-varying HbA1c (HR: 1.500), and HbA1c SD (HR: 1.665) each independently predicted CVD events over 14.3 ± 5.2 person-years of follow-up.
"We found that several hemoglobin A1C positively correlated with CAC volume and independently predicted CVD events in the CACTI T1D cohort," the researchers wrote. "These associations with cardiovascular events persisted for mean HbA1c, baseline HbA1c, and time-varying HbA1c even after adjusting for numerous CVD risk factors."
Reference:
William B Horton, MD, MSc, FACP, Janet K Snell-Bergeon, PhD, MPH, HbA1c Variability Metrics Predict Coronary Artery Calcium and Cardiovascular Events in Type 1 Diabetes: the CACTI Study, The Journal of Clinical Endocrinology & Metabolism, 2023;, dgad019, https://doi.org/10.1210/clinem/dgad019
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751